Perspective Therapeutics, Inc. (CATX)
2.885
+0.08
(+2.67%)
USD |
NYAM |
Jan 07, 16:00
2.88
0.00 (0.00%)
After-Hours: 18:09
Perspective Therapeutics Research and Development Expense (Annual): 39.33M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Outset Medical, Inc. | 36.29M |
| InfuSystem Holdings, Inc. | -- |
| Xtant Medical Holdings, Inc. | 2.385M |
| VolitionRX Ltd. | 13.32M |
| Catheter Precision, Inc. | 0.272M |